Literature DB >> 2817920

'Vasoconstriction'--skin blanching--assay for glucocorticoids--a critique.

V P Shah1, C C Peck, J P Skelly.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2817920     DOI: 10.1001/archderm.125.11.1558

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  5 in total

1.  A history of biopharmaceutics in the Food and Drug Administration 1968-1993.

Authors:  Jerome Philip Skelly
Journal:  AAPS J       Date:  2009-11-20       Impact factor: 4.009

2.  Analysis of chromameter results obtained from corticosteroid-induced skin blanching. I: Manipulation of data.

Authors:  E W Smith; J M Haigh; R B Walker
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

3.  Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.

Authors:  G J Singh; N Fleischer; L Lesko; R Williams
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

4.  Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.

Authors:  P H Demana; E W Smith; R B Walker; J M Haigh; I Kanfer
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

5.  Probe Sensitivity to Cortical versus Intracellular Cytoskeletal Network Stiffness.

Authors:  Amir Vahabikashi; Chan Young Park; Kristin Perkumas; Zhiguo Zhang; Emily K Deurloo; Huayin Wu; David A Weitz; W Daniel Stamer; Robert D Goldman; Jeffrey J Fredberg; Mark Johnson
Journal:  Biophys J       Date:  2019-01-07       Impact factor: 4.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.